Back to Search Start Over

CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors

Authors :
Magdalena Sauvage
Jill R. Crittenden
Shenyu Zhai
Cinzia Costa
Walker S. Jackson
Anne C. Smith
Veronica Ghiglieri
David E. Housman
David Sulzer
Ann M. Graybiel
Giuseppina Martella
D. James Surmeier
Takashi Kitsukawa
Eric Burguière
Karen A. Pescatore
Ellen M. Unterwald
Barbara Picconi
Hui Zhang
Morgane Thomsen
Paolo Calabresi
S. Barak Caine
McGovern Institute for Brain Research [Cambridge]
Massachusetts Institute of Technology (MIT)
Department of Brain and Cognitive Sciences
Feinberg School of Medicine
Northwestern University [Evanston]
Graduate School of Frontier Biosciences [Osaka]
Osaka University [Osaka]
Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM)
Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
McLean Hospital [Belmont, Ma.]
Harvard Medical School [Boston] (HMS)
New York State Psychiatric Institute
Columbia University [New York]
Università degli Studi di Perugia (UNIPG)
Fondazione Santa Lucia [IRCCS]
Clinical and Behavioral Neurology [IRCCS Santa Lucia]
Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie] (UniSR)
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS San Raffaele Pisana)
Temple University [Philadelphia]
Pennsylvania Commonwealth System of Higher Education (PCSHE)
Linköping University (LIU)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University of Arizona
Northwestern University Medical School [Chicago]
CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Jefferson (Philadelphia University + Thomas Jefferson University)
IRCCS San Raffaele Pisana
Temple University School of Medicine
Università cattolica del Sacro Cuore [Roma] (Unicatt)
Gestionnaire, Hal Sorbonne Université
Institut du Cerveau = Paris Brain Institute (ICM)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Università degli Studi di Perugia = University of Perugia (UNIPG)
Source :
Neurobiology of disease, Neurobiology of Disease, Neurobiology of Disease, Elsevier, 2021, 158, pp.105473. ⟨10.1016/j.nbd.2021.105473⟩, Neurobiology of Disease, Vol 158, Iss, Pp 105473-(2021), Neurobiology of disease, 158:105473, Elsevier, Neurobiology of Disease, 2021, 158, pp.105473. ⟨10.1016/j.nbd.2021.105473⟩
Publication Year :
2021

Abstract

CalDAG-GEFI (CDGI) is a protein highly enriched in the striatum, particularly in the principal spiny projection neurons (SPNs). CDGI is strongly down-regulated in two hyperkinetic conditions related to striatal dysfunction: Huntingtons disease and levodopa-induced dyskinesia in Parkinsons disease. We demonstrate that genetic deletion of CDGI in mice disrupts dendritic, but not somatic, M1 muscarinic receptors (M1Rs) signaling in indirect pathway SPNs. Loss of CDGI reduced temporal integration of excitatory postsynaptic potentials at dendritic glutamatergic synapses and impaired the induction of activity-dependent long-term potentiation. CDGI deletion selectively increased psychostimulant-induced repetitive behaviors, disrupted sequence learning, and eliminated M1R blockade of cocaine self-administration. These findings place CDGI as a major, but previously unrecognized, mediator of cholinergic signaling in the striatum. The effects of CDGI deletion on the selfadministration of drugs of abuse and its marked alterations in hyperkinetic extrapyramidal disorders highlight CDGIs therapeutic potential. Funding Agencies: William N. & Bernice E. Bumpus Foundation; Saks Kavanaugh Foundation; Simons Foundation; National Institute of Child Health and Development United States Department of Health & Human Services National Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37 HD028341]; James and Pat Poitras Research Fund; Stanley Center for Psychiatric Research at the Broad Institute; National Institute of Mental Health United States Department of Health & Human Services National Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH071847, F32 MH065815]; National Institute on Aging United States Department of Health & Human Services National Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG050548]; European Community FP7 - The-matic priority HEALTH contract [222918]; Ministry of Health; JPB Foundation; National Institute on Drug Abuse United States Department of Health & Human Services National Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) European Commission [R00 DA027825, R01 DA07418]

Details

Language :
English
ISSN :
1095953X and 09699961
Volume :
158
Database :
OpenAIRE
Journal :
Neurobiology of disease
Accession number :
edsair.doi.dedup.....0e9d40a8e94ed843df213514512c582c
Full Text :
https://doi.org/10.1016/j.nbd.2021.105473⟩